Heavy rains and rush of water from upstream in India’s northeast have inundated large swathes of Sylhet division, leaving thousands stranded and triggering a humanitarian crisis.
GlycoMantra, a University of Maryland, Baltimore (UMB) startup company developing therapeutics for unmet medical needs in prostate cancer, NASH liver fibrosis, and type 2 diabetes, has been granted worldwide, exclusive rights to a UMB technology to advance the company's pipeline of therapeutics for treating drug-resistant metastatic colorectal cancer (mCRC).